Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARMS: Posoleucel for Multivirus Infection Post-HSCT
NCT01570283Phase 2Completed
- Sponsor
- AlloVir
- Start
- Sep 2012
- Primary completion
- Aug 2016
- Modality
- Native Immune Cells
- Countries
- 1
01
Overview
A Phase 2 trial of posoleucel in cytomegalovirus infection (CMV), Epstein-Barr virus infection, adenovirus infection, BK virus infection, human herpesvirus 6 infection, sponsored by AlloVir. Started Sep 2012; status: completed.
02
Drugs
posoleucel
03
Conditions
cytomegalovirus infection (CMV)Epstein-Barr virus infectionadenovirus infectionBK virus infectionhuman herpesvirus 6 infection
Beyond the preview
Go deeper on NCT01570283.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01570283.